Profil
Mr. Jeffrey Gruenglas was previously employed as an Executive Director-Government Affairs by ADMA Biologics, Inc., a Managing Partner by New England Research Group, Inc., a Member by The Alpha Eta Society, and a Member by The Honor Society of Phi Kappa Phi.
He received his undergraduate degree from Brooklyn College, an undergraduate degree from Harvard Medical School and a doctorate degree from Massachusetts College of Pharmacy & Health Science.
Ehemalige bekannte Positionen von Jeffrey Gruenglas
| Unternehmen | Position | Ende |
|---|---|---|
The Alpha Eta Society | Corporate Officer/Principal | - |
New England Research Group, Inc. | Corporate Officer/Principal | - |
The Honor Society of Phi Kappa Phi
The Honor Society of Phi Kappa Phi Miscellaneous Commercial ServicesCommercial Services Operates as a society that dedicated to recognition and promotion of academic excellence | Corporate Officer/Principal | - |
| ADMA BIOLOGICS, INC. | General Counsel | - |
Ausbildung von Jeffrey Gruenglas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
ADMA Biologics, Inc.
ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
Brooklyn College
Brooklyn College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Honor Society of Phi Kappa Phi
The Honor Society of Phi Kappa Phi Miscellaneous Commercial ServicesCommercial Services Operates as a society that dedicated to recognition and promotion of academic excellence | Commercial Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Alpha Eta Society | |
New England Research Group, Inc. |
















